LCN2 and hematopoietic and lymphoid cell neoplasm: A few studies measuring NGAL protein levels in the bone marrow (BM) of patients with hematological cancer reported that NGAL levels were significantly lower in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) than in controls 8-10.